Core Viewpoint - Yirui Technology (688301.SH), a domestic core component supplier for medical imaging, is accelerating its industrial layout through an investment of up to 1.8 billion yuan in a silicon-based OLED microdisplay backplane production project [1][2]. Investment and Expansion - The company plans to increase its investment in its wholly-owned subsidiary, Yirui Imaging Technology (Hefei) Co., Ltd., by 600 million yuan to implement the silicon-based OLED microdisplay backplane production project [2][3]. - The project aims to add a production capacity of 5,000 units per month, with a construction period of 12 months and an expected payback period of 6.7 years, yielding an internal rate of return of 11.01% [2][3]. R&D Investment - From 2020 to 2024, Yirui Technology's cumulative R&D investment reached 1.053 billion yuan, with annual investments showing a growth trend: 96 million yuan in 2020, 146 million yuan in 2021, 239 million yuan in 2022, 262 million yuan in 2023, and 310 million yuan in 2024 [3][4]. Market Position and Performance - Yirui Technology is a leading player in the digital X-ray detector market, with production bases located in Shanghai, Jiangsu, Zhejiang, and Seoul, South Korea [4]. - In 2024, the company reported a revenue of 1.831 billion yuan, a year-on-year decrease of 1.74%, and a net profit of 465 million yuan, down 23.43% [5][6]. Globalization Efforts - In 2024, Yirui Technology enhanced its global presence by establishing sales or customer service platforms in the United States, Germany, and South Korea [6]. - The company also plans to issue shares to specific investors to raise funds for the construction of X-ray vacuum devices and comprehensive solution projects, which will add significant production capacity [6].

Core Viewpoint - The article discusses the rising investment in the Micro OLED sector driven by the increasing demand for AR glasses and the establishment of new production projects by various companies in the industry [1][11]. Company Investment - Yisui Technology plans to invest up to 1.8 billion yuan in a Micro OLED micro-display backplane production project, with an additional 600 million yuan allocated to its wholly-owned subsidiary, Yisui Imaging Technology (Hefei) [2][5]. - The project aims to add a production capacity of 5,000 units per month to meet specific customer demands, particularly from Shiya Technology [5][6]. Industry Development - The Micro OLED sector is experiencing a surge in project launches, with multiple companies, including Hongxi Technology and Xitai Technology, announcing significant investments and new production lines [7][9]. - Shiya Technology currently operates a 12-inch evaporation line capable of producing 9,000 wafers per month, with plans to expand to three lines producing 27,000 wafers per month [7][10]. Market Demand - The demand for Micro OLED displays is expected to grow, particularly in AR glasses, where it is projected to account for 54% of the market share by 2024 [10]. - Micro OLED technology is also anticipated to find applications in various fields, including security monitoring, digital camera viewfinders, military targeting devices, medical equipment, industrial inspection, and automotive displays [10][11]. Future Outlook - The Micro OLED technology is expected to see further development by 2025, leading to increased investments in upstream core component projects and a more mature industry chain [11].

Group 1 - The Shanghai Composite Index turned positive on May 26, with the Sci-Tech Innovation Index rising by 0.28%, driven by stocks like Kejie Intelligent and Zhongyou Technology, which saw significant gains [1] - The Tianhong Sci-Tech Innovation Index ETF (589860) reported a trading volume exceeding 48 million yuan and a turnover rate of over 5.7%, indicating active trading [1] - The Tianhong ETF experienced a net inflow of 14.73 million yuan on May 23, reflecting investor interest in the Sci-Tech Innovation Index [1] Group 2 - The overall profitability of companies listed on the Sci-Tech Innovation Board is continuously improving, with over 80% of these companies concentrated in high-tech and strategic emerging industries [2] - The average R&D investment of Sci-Tech Innovation Board companies reached 12.64% of their operating income in 2022, totaling 168.08 billion yuan, which is 2.5 times their net profit [2] - Companies with high R&D investment ratios are primarily found in sectors with high technical barriers and long R&D cycles, such as biomedicine, semiconductors, and artificial intelligence [2]

Group 1 - The core viewpoint is that the Chinese innovative drug industry is entering a critical turning point for value reassessment, supported by government policies and the performance of leading companies [1][2] - The Shanghai Stock Exchange Science and Technology Innovation Board Biopharmaceutical Index has shown mixed performance, with some stocks like Yirui Technology rising over 8% [1] - The Science and Technology Innovation Board Biopharmaceutical Index ETF closely tracks the performance of the biopharmaceutical sector, reflecting the overall performance of representative companies in this industry [1] Group 2 - Century Securities indicates that the innovative drug sector is undergoing a systematic value reassessment, with increasing recognition of domestic innovative drugs by overseas pharmaceutical companies [2] - The industry is transitioning from a phase of capital bubble to a stage where domestic innovations are gaining international recognition, suggesting a significant shift in the market dynamics [2] - Recommendations include focusing on biotech companies with reasonable valuations and differentiated innovation platforms, as well as exploring opportunities in AI-related medical fields [2]

Group 1 - The meeting of the third Supervisory Board was held both on-site and via communication methods, with all three supervisors present and voting [1] - The Supervisory Board approved the proposal for additional related party transactions for the year 2025, stating that the transactions are necessary for the company's business development and comply with legal regulations [1] - The voting result for the proposal was 2 votes in favor, 0 against, and 0 abstentions, with the related supervisor abstaining from the vote [2] Group 2 - The proposal for additional related party transactions will be submitted for approval at the company's shareholders' meeting [2]

Meeting Information - The second extraordinary general meeting of shareholders will be held on June 9, 2025, at 14:30 [1] - The meeting will take place at the conference room of Iray Technology Group Co., Ltd., located at 999 Huanqiao Road, Pudong New District, Shanghai [1] - Voting will be conducted through a combination of on-site and online voting methods [1] Voting Procedures - The online voting system will be the Shanghai Stock Exchange's shareholder meeting online voting system, available from 9:15 to 15:00 on the day of the meeting [1][2] - Shareholders can vote via the trading system or the internet voting platform, with specific time slots for each [1][2] - Shareholders must complete identity verification to vote on the internet platform [2] Meeting Agenda - The meeting will review proposals that have been approved by the company's board of directors and supervisory board [2] - Related shareholders who must abstain from voting include Shanghai Yiyuan He Rui Investment Consulting Co., Ltd. and others [2] Attendance Requirements - Shareholders registered with China Securities Depository and Clearing Co., Ltd. as of June 3, 2025, are eligible to attend [4] - Shareholders must register in advance to attend the meeting, with specific registration times and methods outlined [5] Additional Services - The company will utilize a reminder service to notify shareholders about the meeting and voting procedures via SMS [4] - Shareholders are advised to arrive early for registration and must bring necessary documentation [6]

Core Viewpoint - The company has announced its expected related party transactions for the year 2025, amounting to RMB 117.85 million, which will be submitted for shareholder approval and is deemed fair and necessary for business operations [1][2][3]. Related Party Transaction Overview - The expected amount for related party transactions in 2025 is RMB 11,785.00 thousand [2]. - The transactions will include sales of products and services to related parties, with a focus on maintaining fair market practices and not harming the interests of minority shareholders [1][5]. Transaction Details - The company plans to engage in transactions with Vision Technology Co., Ltd., including the sale of silicon-based OLED microdisplay modules and the receipt of performance guarantees [4][5]. - The performance guarantees will not be used to offset payment for goods and will be returned based on actual procurement amounts [4]. Approval Process - The related party transactions have been reviewed and approved by the board of directors and will be presented to the shareholders for final approval [3][5]. - Independent directors and non-related board members participated in the decision-making process to ensure fairness [3]. Necessity and Fairness of Transactions - The related party transactions are necessary for the company's operational needs and are conducted under fair market conditions [5]. - The company maintains a stable partnership with related parties, which supports its ongoing business development without compromising independence [5].

Investment Overview - The company plans to invest up to RMB 1.8 billion (approximately USD 270 million) in the silicon-based OLED microdisplay backplane production project, with an increase of RMB 600 million (approximately USD 90 million) to its wholly-owned subsidiary, Yirui Imaging Technology (Hefei) Co., Ltd [3][4] - The investment aims to enhance production capacity by adding 5,000 units per month and achieving large-scale production [4] Decision and Approval Process - The investment proposal was approved during the 15th meeting of the company's third board of directors on May 23, 2025, and will be submitted for shareholder approval [2][3] Project Background - The company aims to establish a partnership with Shiya Technology and specific clients, where Shiya Technology will provide silicon-based OLED microdisplay module products, and the company will supply the necessary core materials [3][4] - The project leverages existing production lines for CMOS sensors, allowing for efficient production of the new backplane [4] Impact on the Company - The investment is expected to create strong synergies with existing operations, enhance technological innovation, and improve collaboration with downstream clients, thereby strengthening the company's competitive edge [4] - The funding will come from the company's own resources and a performance bond from Shiya Technology, ensuring no adverse impact on normal operations [4]

重要内容提示： 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 召开会议的基本情况 | 证券代码：688301 | 证券简称：奕瑞科技 | 公告编号：2025-036 | | --- | --- | --- | | 转债代码：118025 | 转债简称：奕瑞转债 | | 奕瑞电子科技集团股份有限公司 关于召开2025年第二次临时股东大会的通知 （一） 股东大会类型和届次 2025年第二次临时股东大会 （二） 股东大会召集人：董事会 （三） 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票 相结合的方式 （四） 现场会议召开的日期、时间和地点 召开日期时间：2025 年 6 月 9 日 14 点 30 分 召开地点：上海市浦东新区环桥路 999 号奕瑞电子科技集团股份有限公司一 楼会议室 （五） 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 6 月 9 日 至2025 年 6 月 9 日 股东大会召开日期：2025年6月9日 本次股东大 ...

2025 年 5 月 23 日，奕瑞电子科技集团股份有限公司（以下简称"公司"）以 现场及通讯方式召开了第三届监事会第十三次会议（以下简称"本次会议"），会 议通知已于 2025 年 5 月 21 日发出。本次会议由监事会主席丰华先生主持，会议 应出席监事 3 人，实际出席并表决的监事 3 人。本次会议的召开及表决程序符合 《中华人民共和国公司法》、《公司章程》等相关法律法规的规定。 二、监事会会议审议情况 （一）审议通过《关于新增 2025 年度关联交易预计的议案》 监事会认为：公司预计新增 2025 年度关联交易符合公司经营业务的发展需 要，交易价格公允，符合法律、法规的规定以及相关制度的要求，未损害公司及 其他非关联方的利益，不存在损害中小股东利益的情形。 | 证券代码：688301 | 证券简称：奕瑞科技 公告编号：2025-033 | | --- | --- | | 转债代码：118025 | 转债简称：奕瑞转债 | 奕瑞电子科技集团股份有限公司 第三届监事会第十三次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法 ...